Your browser doesn't support javascript.
loading
Electrocardiographic parameters associated with pacemaker induced cardiomyopathy.
Loring, Zak; Giczewska, Anna; Hofmann, Paul; Chiswell, Karen; Schlegel, Todd T; Ugander, Martin; Jackson, Kevin P; Piccini, Jonathan P; Atwater, Brett D.
Afiliação
  • Loring Z; Duke Clinical Research Institute, Durham, NC, USA; Division of Cardiology, Department of Medicine, Duke University, Durham, NC, USA. Electronic address: zak.loring@duke.edu.
  • Giczewska A; Duke Clinical Research Institute, Durham, NC, USA.
  • Hofmann P; Duke Clinical Research Institute, Durham, NC, USA.
  • Chiswell K; Duke Clinical Research Institute, Durham, NC, USA.
  • Schlegel TT; Nicollier-Schlegel SARL, Trelex, Vaud, Switzerland; Department of Clinical Physiology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Ugander M; Department of Clinical Physiology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden; Kolling Institute, Royal North Shore Hospital, University of Sydney, Sydney, Australia.
  • Jackson KP; Division of Cardiology, Department of Medicine, Duke University, Durham, NC, USA.
  • Piccini JP; Duke Clinical Research Institute, Durham, NC, USA; Division of Cardiology, Department of Medicine, Duke University, Durham, NC, USA.
  • Atwater BD; Inova Heart and Vascular Institute, Falls Church, VA, USA.
J Electrocardiol ; 77: 17-22, 2023.
Article em En | MEDLINE | ID: mdl-36549180
BACKGROUND: Chronic right ventricular (RV) pacing can induce left ventricular (LV) dyssynchrony and cause pacemaker induced cardiomyopathy (PiCM). Identifying which patients are at risk for PiCM is limited. METHODS: Patients receiving RV-only permanent pacemakers (PPMs) at Duke University Medical Center between 2011 and 2017 who had normal baseline ejection fractions (EFs) were identified. Patients who developed a subsequent decrease in EF, died, or underwent cardiac resynchronization therapy, left ventricular assist device, or heart transplant without a competing cause were considered as the primary endpoint. Pre-PPM and post-PPM electrocardiograms (ECGs) were analyzed to extract scalar measurements including the lead one ratio (LOR) as well as advanced-ECG (A-ECG) features to identify predictors of PiCM. Traditional and penalized Cox regression were used to identify variables predictive of the primary endpoint. RESULTS: Pre-PPM ECGs were evaluated for 404 patients of whom 140 (35%) experienced the primary endpoint. Predictors included female sex (hazard ratio [HR] 1.14), a T' wave in V6 (HR 1.31), a P' wave in aVL (HR 0.88), and estimated glomerular filtration rate (HR 0.88). Post-PPM ECGs were evaluated for 228 patients for whom 94 (41%) experienced the primary endpoint. Predictors included female sex (HR 0.50), age (HR 1.06), and a history of congestive heart failure (HR 1.63). Neither LOR nor A-ECG parameters were strong predictors of the primary endpoint. CONCLUSIONS: Baseline and paced ECG data provide limited insight into which patients are at high risk for developing PiCM.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Marca-Passo Artificial / Terapia de Ressincronização Cardíaca / Insuficiência Cardíaca / Cardiomiopatias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Marca-Passo Artificial / Terapia de Ressincronização Cardíaca / Insuficiência Cardíaca / Cardiomiopatias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article